GO
Loading...

Eli Lilly CEO Sounds Off

Tuesday, 17 Aug 2010 | 8:47 AM ET

Eli Lilly is halting the development of an Alzheimer's drug, with John Lechleiter, Eli Lilly chairman & CEO.